Abstract
BackgroundThe effectiveness of TNF blockers in treating axial Spondyloarthritis is well-known but there are a few evidence on the dosage reduction in patients in persistent clinical remission (1-4).ObjectivesOur objective was...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
